‘Collision with reality’: The $100 billion downfall of an Aussie giant

CSL investors had already torched tens of billions of dollars of wealth on the biomedical giant before the year had even started, and a sense of panic must have set in when its chief executive, Dr Paul McKenzie, abruptly resigned the day before its half-year results announcement in February.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.